Taurine and Its Chloramine: Modulators of Immunity

Neurochemical Research

Volumn 29, Issue 1, 2004, Pages 117-126

  Schuller Levis, Georgia B ^a,b   Park, Eunkyue ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b IBR   (United States)

Author keywords

Cysteine sulfinic acid decarboxylase; Inflammatory mediators; Nitric oxide; Taurine; Taurine chloramine; Tumor necrosis factor alpha

Indexed keywords

ALPHA ACTIN; AMINO ACID TRANSPORTER; CHLORAMINE DERIVATIVE; CYCLOOXYGENASE 2; CYSTEINE SULFINIC ACID; CYTOKINE; GAMMA INTERFERON; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; METHIONINE; MYELOPEROXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; TAURINE CHLORAMINE; TAURINE DERIVATIVE; TAURINE TRANSPORTER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URIDINE DERIVATIVE;

AMINO ACID DEFICIENCY; APOPTOSIS; CYTOKINE PRODUCTION; HUMAN; IMMUNITY; IMMUNOMODULATION; INFERTILITY; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE; MACROMOLECULE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTECTION; RETINA DEGENERATION; REVIEW; TISSUE INJURY;

ANIMALS; CARRIER PROTEINS; HUMANS; IMMUNITY; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, ANIMAL; TAURINE;

BOVINAE; MAMMALIA; RODENTIA;

EID: 0842279569     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000010440.37629.17     Document Type: Review

References (44)

1. Huxtable, R. J. 1992. The physiological actions of taurine. Physiol. Rev. 72:101-163.
2. Sturman, J. A. 1993. Taurine in development. Physiol. Rev. 73: 119-148.
3. Schuller-Levis, G., Mehta, P. D., Rudelli, R., and Sturman, J. A. 1990. Immunologic consequence of taurine deficiency in cats. J. Leukoc. Biol. 47:321-333.
4. Fukuda, K., Hirai, Y., Yoshida, H., Hakajima, T., and Usii, T. 1982. Free-amino acid content of lymphocytes and granulocytes compared. Clin. Chem. 28:1758-1761.
5. Parcell, S. 2002. Sulfur in human nutrition and applications in medicine. Altern. Med. Rev. 7:22-44.
6. Schuller-Levis, G., Mehta, P. D., Rudelli, R., and Sturman, J. 1990. Immunologic consequences of taurine deficiency in cats. J. Leukoc. Biol. 47:321-331.
7. 2-induced alterations. Am. J. Pathol. 125:585-600.
8. Giri, S. N., Biring, I., Nguyen, T., Wang, G., and Hyde, D. M. 2002. Abrogation of bleomycin-induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice. Nitric Oxide 7:109-118.
9. Wang, Q., Giri, S. N., Hyde, D. M., and Li, C. 1991. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem. Pharmacol. 42:1115-1122.
10. Gordon, R. E. and Heller, R. F. 1992. Taurine protection of lungs in hamster models of oxidant injury: A morphological time study of paraquat and bleomycin treatment. Pages 319-328, in Lombardini, J. B. (ed.), Taurine. New York: Plenum Press.
11. Schuller-Levis, G., Quinn, M. R., Wright, C., Park, and E. 1994. Taurine protects against oxidant-induced lung injury: Possible mechanism(s) of action. Adv. Exp. Med. Biol. 359:31-39.
12. Schuller-Levis, G., Gordon, R. E., Wang, C., and Park, E. 2003 Taurine reduces lung inflammation and fibrosis caused by bleomycin. Adv. Exp. Med. Biol. 526:395-402.
13. Abdih, H., Kelly, C. J., Bouchier-Hayes, D., Barry, M., and Kearns, S. 2000. Taurine prevents interleukin-2-induced acute lung injury in rats. Eur. Surg. Res. 32:347-352.
14. Egan, B. M., Abdih, H., Kelly, C. J., Condron, C., and Bouchier-Hayes, D. J. 2001. Effect of intravenous taurine on endotoxin-induced acute lung injury in sheep. Eur. J. Surg. 167:575-580.
15. Huat, A. and Hacker, M. 1990. Role of reactive nitrogen intermediate production in alveolar macrophage mediated cytostatic activity induced by bleomycin lung damage in rats. Cancer Res. 50:7863-7866.
16. Vanhee, D., Delneste, Y., Lassalle, P., Gosset, P., Joseph, M., and Tonnel, A.B. 1994. Modulations of endothial cell adhesion molecule expression in a situation of chronic inflammatory stimulation. Cell. Immunol. 155:446-456.
17. Grisham, M. B., Jefferson, M. M., Melton, D. F., and Thomas, E. L. 1984. Chlorination of endogenous amines by isolated neutrophils. J. Biol. Chem. 259:10404-10413.
18. Weiss, S. J. R., Klein, A., Slivka, A., and Wei, M. 1982. Chlorination of taurine by human neutrophils: Evidence for hypochlorous acid generation. J. Clin. Invest. 70:598-607.
19. Park, E., Quinn, M. R., Wright, C. E., and Schuller-Levis, G. 1993. Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J. Leukoc. Biol. 54:119-124.
20. Park, E., Schuller-Levis, G., and Quinn, M. R. 1995. Taurine chloramine inhibits production of nitric oxide and TNF-α in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J. Immunol. 154: 4778-4784.
21. 2 production in activated RAW 264.7 cells by post-transcriptional effects on inducible cyclooxygenase expression. Immunol. Lett. 50:185-188.
22. Marcinkiewicz, J., Grabowska, A., Bereta, J., and Stelmaszynska, T. 1995. Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J. Leukoc. Biol. 58:667-674.
23. Park, E., Alberti, J., Quinn, M. R., and Schuller-Levis, G. 1998. Taurine chloramine inhibits production of superoxide anion, IL-6 and IL-8 in activated human polymorphonuclear leukocytes. Adv. Exp. Med. Biol. 442:177-182.
24. Park, E., Jia, J.-H., Quinn, M. R., and Schuller-Levis, G. 2002. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin. Immunol. 102:179-184.
25. Choray, M., Konmy, E., Marcinkiewicz, J., and Maslinski, W. 2002. Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells. Amino Acids 23:407-441.
26. Marcinkiewicz, J., Nowak, B., Grabowska, A., Bobek, M., Petrovska, L., and Chain, B. 1999. Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system. Immunol. 98:371-378.
27. Park, E., Schuller-Levis, G., Jin, H., and Quinn, M. R. 1997. Preactivation exposure of RAW 264.7 cells to taurine chloramine attenuates subsequent production of nitric oxide and expression of iNOS in RNA. J. Leukoc. Biol. 61:161-166.
28. Englert, R. P. and Shacter, E. 2002. Distinct modes of cell death induced by different reactive oxygen species. J. Biol. Chem. 277:20518-20526.
29. Kwasny-Krochin, B., Bobek, M., Kontny, E., Gluszko, P., Biedron, R., Chain, B. M., Maslinski, W., and Marcinkiewicz, J. 2002. Effect of taurine chloramine, the product of activated neutrophils, on the development of collagen-induced arthritis in DBA I/J mice. Amino Acids 23:419-426.
30. Ibrahim, S. M., Koczan, D., and Thiesen, H. J. 2002. Gene-expression profile of collagen-induced arthritis. J. Autoimmune 18:159-167.
31. Kontny, E., Szczepanska, K., Kowalczewski, J., Kurowska, M., Janicka, I., Marcinkiewicz, J., and Maslinski, W. 2000. The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum. 43:2169-2177.
32. Barua, M., Liu, Y., and Quinn, M. R. 2002. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-α gene expression in activated alveolar macrophages: Decreased NF-κB activation and IκB kinase activity. J. Immunol. 167:2275-2281.
33. Suzuki, T., Suzuki, T., Wada, T., Saigo, K., and Watanabe, K. 2002. Taurine as a constituent of mitochondrial tRNA: New insights into the functions of taurine and human mitochondrial diseases. EMBO J. 21:6581-6589.
34. Kanayama, A., Inoue, J., Sugita-Konishi, Y., Shimizu, M., and Miyamoto, Y. 2002. Oxidation of IκBα at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-κB activation. J. Biol. Chem. 277:24049-24056.
35. Reymond, I., Sergeant, A., and Tappaz, M. 1996. Molecular cloning and sequence analysis of the cDNA encoding rat liver cysteine sulfinate decarboxylase (CSD). Biochim. Biophys. Acta 1307:152-156.
36. Kaisaki, P. J., Jerkin, A. A., Goodspeed, D. C., and Steel, R. D. 1995. Cloning and characterization of rat cysteine sulfinic acid decarboxylase. Biochim. Biophys. Acta 1262:79-82.
37. Park, E., Park, S. Y., Wang, C., Xu, J., LaFauci, G., and Schuller-Levis, G. 2002. Cloning of murine cysteine sulfinic acid decarboxylase and its mRNA expression in murine tissues. Biochim. Biophys. Acta 1574:403-406.
38. Hosokawa, Y., Matsumoto, A., Oka, J., Itakura, H., and Yamaguchi, K. 1990. Isolation and characterization of a complementary DNA for rat liver cysteine dioxygenase. Biochem. Biophys. Res. Commun. 168:473-478.
39. Bella, D. L., Kwon, Y. H., Hirschberger, L. L., and Stipanuk, M. H. 2000. Post-transcriptional regulation of cysteine dioxygenase in rat liver. Adv. Exp. Med. Biol. 483:71-85.
40. Han, X., Budreau, A. M., Chesney, R. W. 2000. Cloning and characterization of the promoter region of the rat taurine transporter (Tau T) gene. Adv. Exp. Med. Biol. 483:97-108.
41. Patel, A., Rochelle, J. M., Jones, J. M., Sumegi, G., Uhl, G. R., Seldin, M. F., Meisler, M. H., and Gregor, P. 1995. Mapping of the taurine transporter gene to mouse chromosome 6 and to the short arm of human chromosome 3. Genomics 1: 314-317.
42. Mowrey, P. N., Chorney, M. J., Venditti, C. P., Latif, F., Modi, W. S., Lerman, M. I., Zbar, B., Robins, D. B., Rogan, P. K., and Ladda, R. L. 1993. Clinical and molecular analyses of deletion 3p25-pter syndrome. Am. J. Med. Genet 46:623-629.
43. Heller-Stilb, B., Van Roeyen, C., Rascher, K., Hartwig, H. G., Huth, A., Seeliger, M. W., Warskulat, U., and Haussinger, D. 2002. Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J. 16:231-233.
44. Han, X., Patters, A. B., and Chesney, R. W. 2002. Transcriptional repression of taurine transporter gene (TauT) by p53 in renal cells. J. Biol. Chem. 277:39266-39273.